• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

What are the Consequences of Taking Triptan for Migraine During Pregnancy?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • 50% of pregnancies are unplanned in the US and migraines are common
    • As a result, early exposure to triptans (serotonin receptor agonists) during pregnancy can be expected
  • Due to lack of data, triptans are used less frequently than acetaminophen or NSAIDS during pregnancy
  • Spielmann et al. (Cephalalgia, 2017) sought to determine the impact of triptan exposure on pregnancy outcome, especially major birth defects and miscarriage

METHODS:

  • Prospective observational cohort study
  • Cohorts
    • Women with migraine disorder exposed to triptans (exposed cohort=432 women)
    • Pregnant women without migraine disorder (non-migraine comparison cohort=1,733 women)
    • Pregnant women with migraine disorder but not taking triptans (migraine comparison cohort=475 women)
  • Primary outcomes were major birth defects and spontaneous abortion
  • Secondary outcomes were preterm delivery, birth weight, pregnancy complications and the rate of electively terminated pregnancies
  • Using a baseline risk of 3% for major birth defects, the power of this study would allow for a detection of a 2.0-fold risk increase

RESULTS:

  • 75% of exposed cohort took triptans in the first trimester
  • 50.3% took triptans 1–5 days during pregnancy and only 2.3% had a total exposure of >50 days
  • Sumatriptan was the most frequently used triptan
  • After adjustments, there was no difference in miscarriage or elective terminations between the exposed cohort and other cohorts
  • The triptan-exposed pregnancies did not have higher rates of birth defects and this result was not altered based on trimester of exposure
  • Rates of preterm delivery or preeclampsia did not differ between the 3 cohorts

CONCLUSION:

  • Triptans were not found to be teratogenic
  • This study did not find a significant teratogenic effect of triptans or migraine
  • Sumatriptan, the most studied triptan, appears an acceptable treatment for pregnant women
  • A detailed fetal ultrasound should be offered in cases of first trimester exposure to less well-studied triptans such as eletriptan or frovatriptan

Learn More – Primary Sources:

Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Acupuncture Decrease Incidence of Migraines?
CDC Guidance: Contraception in Women with Medical Conditions

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site